Introduction Establishing robust Oligonucleotide CMC Specifications requires addressing unique regulatory challenges because therapeutic oligonucleotides possess physical, chemical, and structural characteristics […]
Introduction Phosphorothioate diastereomers present significant challenges in oligonucleotide characterization. This is because replacing a non-bridging oxygen atom in the phosphodiester
Introduction Native Chemical Ligation provides a chemo- and regioselective chemical approach for joining unprotected synthetic peptide segments to produce full-length
Native Chemical Ligation: Building Small Proteins From Synthetic Peptide Fragments Read More »
Introduction The Oligonucleotide Capacity Challenge highlights the growing industrial mismatch between the rapidly increasing global therapeutic demand for small interfering
Introduction Oligonucleotide Purification Explained focuses on assessing Anion-Exchange Chromatography (AEX) and Ion-Pair Reversed-Phase Chromatography (IP-RP), the two primary chromatographic techniques
Introduction: Peptide-Oligonucleotide Conjugation Optimization is the systematic tuning of chemistry, reaction conditions, monitoring and purification so that a peptide and
Case Study: Improving Conjugation Yield in a Complex Peptide-Oligonucleotide Program Read More »
Introduction Quality control of Oligonucleotide Starting Materials involves systematic analytical characterization, impurity quantification, and physical validation of phosphoramidites and functionalized
Introduction Therapeutic oligonucleotide manufacturing depends on Phosphoramidite Solid-Phase Synthesis to assemble custom single-stranded and double-stranded nucleic acid sequences at scales
Introduction: Peptide-Oligonucleotide Conjugation Yield Optimization is the systematic improvement of the reaction and recovery processes used to make a peptide-linked
Case Study: Improving Conjugation Yield in a Complex Peptide-Oligonucleotide Program Read More »
Introduction: Peptide-oligonucleotide conjugates for oncology are engineered molecules in which a peptide is chemically linked to an oligonucleotide designed to
Peptide-Oligonucleotide Conjugates for Oncology Therapeutics Read More »
